Published in Am Heart J on August 01, 2007
Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol (2009) 3.42
Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J Am Coll Cardiol (2013) 2.89
Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med (2009) 2.15
Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail (2012) 1.92
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study. Eur Heart J (2012) 1.89
Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med (2008) 1.88
Outcomes in patients with heart failure treated in hospitals with varying admission rates: population-based cohort study. BMJ Qual Saf (2014) 1.61
Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc (2010) 1.51
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? J Card Fail (2015) 1.40
Impact of comorbidity on mortality among older persons with advanced heart failure. J Gen Intern Med (2011) 1.31
Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail (2009) 1.24
Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure. CMAJ (2009) 1.10
Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis. Am Heart J (2008) 1.10
Low numeracy is associated with increased odds of 30-day emergency department or hospital recidivism for patients with acute heart failure. Circ Heart Fail (2012) 0.99
Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. Am Heart J (2010) 0.94
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation (2015) 0.89
Predictors of re-hospitalization in patients with chronic heart failure. World J Cardiol (2012) 0.88
Prospective development and validation of a model to predict heart failure hospitalisation. Heart (2014) 0.86
Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study. Circ Heart Fail (2013) 0.83
Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool. JACC Heart Fail (2015) 0.82
Health literacy and mortality: a cohort study of patients hospitalized for acute heart failure. J Am Heart Assoc (2015) 0.82
Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group. Acad Emerg Med (2014) 0.82
The Prevention of Hospital Readmissions in Heart Failure. Prog Cardiovasc Dis (2015) 0.81
Impact of prior admissions on 30-day readmissions in medicare heart failure inpatients. Mayo Clin Proc (2014) 0.80
Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes. Indian Heart J (2016) 0.80
Initial management of patients with acute heart failure. Heart Fail Clin (2013) 0.79
Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial. Eur J Heart Fail (2012) 0.77
Diuretics as pathogenetic treatment for heart failure. Int J Gen Med (2011) 0.77
Who has advanced heart failure?: definition and epidemiology. Congest Heart Fail (2011) 0.77
The challenge of heart failure discharge from the emergency department. Curr Heart Fail Rep (2012) 0.77
Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study. Tex Heart Inst J (2015) 0.76
Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine. Am J Cardiovasc Drugs (2016) 0.75
Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failure. Clin Biochem (2017) 0.75
Hospice Enrollment in Patients With Advanced Heart Failure Decreases Acute Medical Service Utilization. Circ Heart Fail (2017) 0.75
Natural history, adherence, or iatrogenic insult: repeat hospitalizations as a predictor of survival. Am Heart J (2007) 0.75
The Impact of Worsening Heart Failure in the United States. Heart Fail Clin (2015) 0.75
Timing and duration of interventions in clinical trials for patients with hospitalized heart failure. Circ Heart Fail (2013) 0.75
Analysis of recurrent events with an associated informative dropout time: Application of the joint frailty model. Stat Med (2016) 0.75
Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients. PLoS One (2017) 0.75
Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation. J Interv Card Electrophysiol (2016) 0.75
A study to improve communication between clinicians and patients with advanced heart failure: methods and challenges behind the working to improve discussions about defibrillator management trial. J Pain Symptom Manage (2014) 0.75
Defining Ambulatory Advanced Heart Failure: MedaMACS and Beyond. Curr Heart Fail Rep (2017) 0.75
Driveline Infection in Ventricular Assist Devices and Its Implication in the Present Era of Destination Therapy. Open J Cardiovasc Surg (2017) 0.75
Creation and validation of the acute heart failure risk score: AHFRS. Intern Emerg Med (2016) 0.75
The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines. Card Fail Rev (2016) 0.75
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research. J Am Coll Cardiol (2017) 0.75
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol (2006) 4.70
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol (2005) 4.26
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98
Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA (2010) 3.85
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78
Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J (2004) 3.37
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09
Medical management of advanced heart failure. JAMA (2002) 3.07
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04
Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA (2011) 3.02
Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98
Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol (2006) 2.81
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm (2008) 2.75
The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med (2010) 2.71
Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71
The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf (2012) 2.70
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol (2008) 2.66
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65
Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56
Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol (2005) 2.55
Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med (2004) 2.52
The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail (2002) 2.45
Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42
Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat (2007) 2.24
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 2.23
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum (2007) 2.18
INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant (2008) 2.17
Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med (2012) 2.13
Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12
Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol (2003) 2.09
Trouble getting started: predictors of primary medication nonadherence. Am J Med (2011) 2.09
Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99
GRACE principles: recognizing high-quality observational studies of comparative effectiveness. Am J Manag Care (2010) 1.98
Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf (2010) 1.96
Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum (2006) 1.95
European healthcare policies for controlling drug expenditure. Pharmacoeconomics (2003) 1.95
Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum (2006) 1.94
Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications. J Am Geriatr Soc (2008) 1.84
One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf (2012) 1.82
Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension (2005) 1.77
Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol (2011) 1.77
Relationship between COX-2 specific inhibitors and hypertension. Hypertension (2004) 1.75
Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm (2010) 1.74
The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf (2011) 1.74
Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol (2009) 1.73
Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol (2011) 1.72
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm (2008) 1.72
Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data. Cancer Causes Control (2007) 1.66
Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation (2008) 1.65
Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med (2007) 1.62
Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications. Med Care (2009) 1.62
Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics. J Manag Care Pharm (2007) 1.62
Impact of baseline heart failure burden on post-implantable cardioverter-defibrillator mortality among medicare beneficiaries. J Am Coll Cardiol (2013) 1.62
Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol (2008) 1.59
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Aff (Millwood) (2010) 1.59
The impact of reducing cardiovascular medication copayments on health spending and resource utilization. J Am Coll Cardiol (2012) 1.58
Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study. BMJ (2013) 1.58
The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf (2012) 1.56
Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol (2009) 1.56
Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information. Med Care (2007) 1.56
Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. Clin Ther (2006) 1.55
Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol (2010) 1.55
Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? Am J Med (2003) 1.53
Underuse of controller medications among children with persistent asthma in the Ohio medicaid population: evolving differences with new medications. Ambul Pediatr (2005) 1.53
Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation (2006) 1.51
Managing drug-risk information--what to do with all those new numbers. N Engl J Med (2009) 1.49
Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther (2010) 1.48
Sudden uncontrollable somnolence and medication use in Parkinson disease. Arch Neurol (2005) 1.48
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace (2012) 1.46
Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm (2009) 1.46
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 1.45
Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Aff (Millwood) (2007) 1.45
Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population. Pharmacoepidemiol Drug Saf (2010) 1.43